Answers are grounded in this paper and cite their sources.
Dynamic 18F-FDG PET enables brain kinetic quantification to study central nervous system involvement in cancer and other systemic diseases, but reliable blood input functions are difficult to obtain on conventional scanners. We used total-body PET to evaluate 18F-FDG kinetic modeling of the brain in healthy subjects and patients with genitourinary cancer (GUC). Methods: Ten patients with GUC and 12 healthy participants underwent a 1-h total-body 18F-FDG dynamic scan, and image-derived input functions were extracted from the aorta. Reversible and irreversible 2-tissue compartment (2Tr and 2Ti, respectively) models were assessed in the gray matter, thalamus, putamen, and brainstem using Akaike information criterion. Microparameters (K1, k2, k3), net influx rate (Ki), and practical model identifiability were assessed, and differences between patients with GUC and healthy participants were investigated. Results: The 2Tr model provided significantly better fits than the 2Ti model (P < 0.05). Ki and SUV were significantly lower in patients with GUC across multiple brain regions. The 2Tr model revealed significant differences in K1, k2, and k3 between the cohorts, independent of age, which were absent or attenuated when the 2Ti model was used. Identifiability analysis confirmed robust parameter estimation with reasonable bias and SD. Conclusion: Total-body dynamic PET enabled robust, noninvasive quantification of brain 18F-FDG kinetics using an image-derived input function. The 2Tr model provided superior time–activity curve fitting and identifiable parameters and revealed group differences in microparameters (K1 and k2) that were not detected with the 2Ti model. These findings suggest alterations in brain metabolism in patients with GUC, warranting further investigation.
No takes yet. Share an insight, caveat, or question.
Holy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: